Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Large Cap
  • Long Ideas
  • News
  • Short Ideas
  • Top Stories
  • Trading Ideas

Benzinga Bulls And Bears Of The Week: Coinbase, Tesla, Apple, Nvidia, Planet Fitness And This Legacy Automaker

By Michael Cohen
Today, 11:48 AM
Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 

AAPL

Read More
1 minute read
  • FDA
  • General
  • Government
  • Health Care
  • Large Cap
  • Legal
  • News

Lawmakers Seek Answers From FDA, Abbott On Nationwide Baby Formula Shortage

By Vandana Singh
May 26, 10:59 AM
FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE: ABT) recalled some baby formula products and closed its manufacturing plant in Sturgis, Michigan. 

ABT

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Government
  • Health Care
  • Large Cap
  • News

US Raises Objection To Johnson & Johnson’s High Cost Lawyer For Talc Bankruptcy Case: Reuters

By Vandana Singh
May 25, 12:25 PM
Johnson & Johnson (NYSE: JNJ) is ready to cough up an hourly rate of $2,465 in a bid to add Hogan Lovells partner Neal Katyal to its legal team for the talc liability case.

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer To Sell 23 Patented Drugs, Vaccines At Lower Prices To Poorer Countries

By Vandana Singh
May 25, 7:45 AM
Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world’s poorest countries.…

PFE

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News

CVS Health To Stop Filling Controlled Substances Prescriptions For Cerebral, Done Health

By Vandana Singh
May 25, 7:30 AM
CVS Health Corp (NYSE: CVS) will stop

CVS

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Small Cap
  • Trading Ideas

This Famed Company Is Working On A Potential Monkeypox Vaccine

By Vandana Singh
May 24, 3:10 PM
As cases of monkeypox continue to rise, Moderna Inc (NASDAQ: MRNA) is probably working on its platform towards finding a vaccine shot against the disease.

BVNKF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer’s Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies

By Vandana Singh
May 24, 8:52 AM
Pfizer Inc (NYSE:PFE) has announced detailed results from two pivotal studies from ELEVATE UC Phase 3 program evaluating etrasimod for active…

PFE

Read More
2 minute read
  • Large Cap
  • Media
  • News
  • Small Cap

Barron’s Latest Picks And Pans: Amazon, Bill.com, Applied Materials, Wix And More

By Michael Cohen
May 21, 5:14 PM
Benzinga reviews this weekend's top stories on Barron's, for additional information on the latest market news, Benzinga Pro offers a 24/7 news feed, live chat and charting software. 

AMAT

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AbbVie Submits FDA Application For Continuous, 24-Hour Infusion Therapy For Parkinson’s

By Vandana Singh
May 20, 3:06 PM
AbbVie Inc (NYSE:ABBV) submitted its FDA marketing application for ABBV-951, a solution of levodopa and carbidopa prodrugs being evaluated in advanced…

ABBV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

CHMP Supports Approval Of Merck’s Keytruda As Adjuvant In Post Surgery Melanoma Setting

By Vandana Singh
May 20, 2:56 PM
European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co…

MRK

Posts navigation

1 2 … 12 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service